skip to main content
Idioma:
Você quis dizer: marina mariana?
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies
Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies

Karpen, Stephen R. ; Dunne, Jessica L. ; Frohnert, Brigitte I. ; Marinac, Marjana ; Richard, Claudia ; David, Sarah E. ; O’Doherty, Inish M.

Diabetologia, 2023-03, Vol.66 (3), p.415-424 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
2
284-OR: How Do Patients and Caregivers Prioritize Outcomes for Type 1 Diabetes (T1D) Treatment?
284-OR: How Do Patients and Caregivers Prioritize Outcomes for Type 1 Diabetes (T1D) Treatment?
Material Type:
Artigo 		Adicionar ao Meu Espaço

284-OR: How Do Patients and Caregivers Prioritize Outcomes for Type 1 Diabetes (T1D) Treatment?

MARINAC, MARJANA ; HUTTON, CAMPBELL T. ; MANSFIELD, CAROL ; SUTPHIN, JESSIE ; GALLAHER, KATHLEEN ; SULLIVAN, SEAN

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1) [Periódico revisado por pares]

New York: American Diabetes Association

Texto completo disponível

Citações Citado por
3
182-OR: C-Peptide and Metabolic Outcomes in Immunotherapy Studies of New-Onset Type 1 Diabetes
182-OR: C-Peptide and Metabolic Outcomes in Immunotherapy Studies of New-Onset Type 1 Diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

182-OR: C-Peptide and Metabolic Outcomes in Immunotherapy Studies of New-Onset Type 1 Diabetes

TAYLOR, PETER ; COLLINS, KIMBERLY S. ; KARPEN, STEPHEN ; ATABAKHSH, ELNAZ ; AHMED, SIMI ; MARINAC, MARJANA ; LATRES, ESTHER ; LAM, ANNA ; SENIOR, PETER A. ; RIGBY, MARK ; GOTTLIEB, PETER ; DAYAN, COLIN

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1 [Periódico revisado por pares]

New York: American Diabetes Association

Texto completo disponível

Citações Citado por
4
Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop
Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop
Material Type:
Artigo 		Adicionar ao Meu Espaço

Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop

Rickels, Michael R ; Stock, Peter G ; de Koning, Eelco J.P ; Piemonti, Lorenzo ; Pratschke, Johann ; Alejandro, Rodolfo ; Bellin, Melena D ; Berney, Thierry ; Choudhary, Pratik ; Johnson, Paul R ; Kandaswamy, Raja ; Kay, Thomas W.H ; Keymeulen, Bart ; Kudva, Yogish C ; Latres, Esther ; Langer, Robert M ; Lehmann, Roger ; Ludwig, Barbara ; Markmann, James F ; Marinac, Marjana ; Odorico, Jon S ; Pattou, François ; Senior, Peter A ; Shaw, James A.M ; Vantyghem, Marie-Christine ; White, Steven

Transplantation, 2018-09, Vol.102 (9), p.1479-1486 [Periódico revisado por pares]

United States: Copyright Wolters Kluwer Health, Inc. All rights reserved

Texto completo disponível

Citações Citado por
5
Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes
Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes

Anderson, Randy L ; DiMeglio, Linda A ; Mander, Adrian P ; Dayan, Colin M ; Linsley, Peter S ; Herold, Kevan C ; Marinac, Marjana ; Ahmed, Simi T

Diabetes care, 2022-10, Vol.45 (10), p.2189-2201 [Periódico revisado por pares]

United States: American Diabetes Association

Texto completo disponível

Citações Citado por
6
Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189-2201
Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189-2201
Material Type:
Artigo 		Adicionar ao Meu Espaço

Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189-2201

Anderson, Randy L ; DiMeglio, Linda A ; Mander, Adrian P ; Dayan, Colin M ; Linsley, Peter S ; Herold, Kevan C ; Marinac, Marjana ; Ahmed, Simi T

Diabetes care, 2022-12, Vol.45 (12), p.3113-3113 [Periódico revisado por pares]

United States: American Diabetes Association

Texto completo disponível

Citações Citado por
7
Defining outcomes for β‐cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop
Defining outcomes for β‐cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop
Material Type:
Artigo 		Adicionar ao Meu Espaço

Defining outcomes for β‐cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop

Rickels, Michael R. ; Stock, Peter G. ; Koning, Eelco J. P. ; Piemonti, Lorenzo ; Pratschke, Johann ; Alejandro, Rodolfo ; Bellin, Melena D. ; Berney, Thierry ; Choudhary, Pratik ; Johnson, Paul R. ; Kandaswamy, Raja ; Kay, Thomas W. H. ; Keymeulen, Bart ; Kudva, Yogish C. ; Latres, Esther ; Langer, Robert M. ; Lehmann, Roger ; Ludwig, Barbara ; Markmann, James F. ; Marinac, Marjana ; Odorico, Jon S. ; Pattou, François ; Senior, Peter A. ; Shaw, James A. M. ; Vantyghem, Marie‐Christine ; White, Steven

Transplant international, 2018-04, Vol.31 (4), p.343-352 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
8
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis

Taylor, Peter N ; Collins, Kimberly S ; Lam, Anna ; Karpen, Stephen R ; Greeno, Brianna ; Walker, Frank ; Lozano, Alejandro ; Atabakhsh, Elnaz ; Ahmed, Simi T ; Marinac, Marjana ; Latres, Esther ; Senior, Peter A ; Rigby, Mark ; Gottlieb, Peter A ; Dayan, Colin M

The lancet. Diabetes & endocrinology, 2023-12, Vol.11 (12), p.915-925 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
9
Preferences for Outcomes Among Adults with Type 1 Diabetes and Caregivers of Children with Type 1 Diabetes
Preferences for Outcomes Among Adults with Type 1 Diabetes and Caregivers of Children with Type 1 Diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preferences for Outcomes Among Adults with Type 1 Diabetes and Caregivers of Children with Type 1 Diabetes

Marinac, Marjana ; Sutphin, Jessie ; Hutton, Campbell ; Klein, Kathleen ; Sullivan, Sean ; Mansfield, Carol

Patient preference and adherence, 2020-01, Vol.14, p.1719-1731 [Periódico revisado por pares]

New Zealand: Taylor & Francis Ltd

Texto completo disponível

Citações Citado por
10
Evidence for C-peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes
Evidence for C-peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evidence for C-peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes

Latres, Esther ; Greenbaum, Carla J ; Oyaski, Maria L ; Dayan, Colin M ; Colhoun, Helen M ; Lachin, John M ; Skyler, Jay S ; Rickels, Michael R ; Ahmed, Simi T ; Dutta, Sanjoy ; Herold, Kevan C ; Marinac, Marjana

Diabetes (New York, N.Y.), 2024-02 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2018  (1)
  2. 2018Até2018  (2)
  3. 2019Até2019  (1)
  4. 2020Até2022  (3)
  5. Após 2022  (4)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.